Park Place Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$307K Buy
3,546
+3,163
+826% +$303K 0.06% 149
2025
Q4
$36.8K Buy
383
+137
+56% +$13.3K 0.01% 371
2025
Q3
$23.4K Hold
246
﹤0.01% 434
2025
Q2
$21.8K Sell
246
-805
-77% -$68.3K 0.01% 464
2025
Q1
$94.4K Buy
1,051
+227
+28% +$20.3K 0.03% 267
2024
Q4
$65.8K Sell
824
-287
-26% -$24.8K 0.02% 325
2024
Q3
$100K Sell
1,111
-1,492
-57% -$126K 0.03% 287
2024
Q2
$205K Sell
2,603
-557
-18% -$45.7K 0.07% 204
2024
Q1
$275K Sell
3,160
-3,653
-54% -$312K 0.1% 194
2023
Q4
$561K Sell
6,813
-4,195
-38% -$320K 0.22% 127
2023
Q3
$863K Buy
11,008
+646
+6% +$54.1K 0.25% 92
2023
Q2
$913K Sell
10,362
-168
-2% -$14.5K 0.26% 90
2023
Q1
$849K Buy
10,530
+88
+0.8% +$7.17K 0.24% 96
2022
Q4
$812K Buy
+10,442
New +$846K 0.23% 110

Other funds holding MDT

Park Place Capital's MDT Position: Q1 2026 in Review

Park Place Capital increased its Medtronic (MDT) stake by 826% in Q1 2026, buying an estimated $303K and bringing the position to 3,546 shares worth $307K. The position accounts for 0.06% of the portfolio, ranked #149.

Park Place Capital first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $913K in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Park Place Capital held 3,546 shares of Medtronic worth $307K as of Q1 2026.
  • Park Place Capital bought 3,163 Medtronic shares in Q1 2026, an estimated $303K.
  • Medtronic made up 0.06% of Park Place Capital's portfolio in Q1 2026, its #149 holding.
  • Park Place Capital first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Medtronic position peaked at $913K in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.